Form 4: Aptevo Therapeutics Director Niederhuber Reports Stock Transactions
SEC Form 4 Filing
Director John Niederhuber reports transactions involving Aptevo Therapeutics' common stock and restricted stock units.
Summary
- John Niederhuber, a director of Aptevo Therapeutics Inc., reported transactions involving the company's securities.
- On June 1, 2024, Niederhuber acquired 7 shares of common stock upon conversion of restricted stock units (RSUs).
- On June 2, 2024, Niederhuber acquired 81 shares of common stock upon conversion of restricted stock units (RSUs).
- The reported transactions reflect the vesting of previously granted RSUs.
- The RSUs convert into common stock on a one-for-one basis.
- All amounts have been adjusted to reflect a 1-for-44 reverse stock split that occurred on March 5, 2024.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company director, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increase in outstanding shares, but the effect is likely negligible.
Key Dates
| Date | Description |
|---|---|
| June 1, 2021 | Reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022. |
| June 1, 2022 | First vesting date of RSUs granted on June 1, 2021. |
| June 2, 2023 | Reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant. |
| March 5, 2024 | Aptevo Therapeutics effected a 1-for-44 reverse stock split. |
| June 1, 2024 | Director acquired 7 shares of common stock upon conversion of RSUs. |
| June 2, 2024 | Director acquired 81 shares of common stock upon conversion of RSUs. |
| June 3, 2024 | Date of Form 4 filing. |
Keywords
Aptevo Therapeutics, Director, Niederhuber, Form 4, Stock Transactions, RSU, Reverse Stock Split, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.